Guided Therapeutics (GTHP) Other Operating Expenses (2010 - 2025)

Guided Therapeutics (GTHP) has 16 years of Other Operating Expenses data on file, last reported at -$173000.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses fell 156.17% year-over-year to -$173000.0; the trailing twelve-month figure through Dec 2025 stood at -$27000.0 (down 105.33% YoY), and the FY2025 full-year result was $169000.0, down 67.87% from the prior year.
• Other Operating Expenses fell to -$173000.0 in Q4 2025, from $22000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $308000.0 in Q4 2024 to a low of -$173000.0 in Q4 2025.
• A 5-year average of $48200.0 and a median of $51500.0 in 2022 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses slumped 205.56% in 2021 and surged 6700.0% in 2023, its largest moves.
• Tracing GTHP's Other Operating Expenses over 5 years: stood at -$38000.0 in 2021, then jumped by 476.32% to $143000.0 in 2022, then sank by 39.86% to $86000.0 in 2023, then soared by 258.14% to $308000.0 in 2024, then slumped by 156.17% to -$173000.0 in 2025.
• Business Quant data shows GTHP's Other Operating Expenses at -$173000.0 in Q4 2025, $22000.0 in Q3 2025, and $51000.0 in Q2 2025.